Psilocybin is 6-fold more effective than nicotine patches to stop smoking in pilot US study with CBT
7 April 2026. Related: Journal scan, Early access.
Journal scan
Short reports on recently published research
Two cases of severe hyperglycemia with injectable CAB/RPV-LA
5 March 2026. Related: Journal scan, Early access, Side effects.
HPV and anal cancer in HIV+ gay men: new campaign in Manchester: anal HPV in gay men on PrEP
7 February 2026. Related: Journal scan, Coinfections and complications, Cancer and HIV.
US funding cuts set to drive 23 million excess deaths in the poorest countries by 2030
5 February 2026. Related: Journal scan, Treatment access.
Do ATIs in HIV cure-related studies cause anxiety?
27 January 2026. Related: Journal scan, Cure-related research.
Achieving greater HIV viral suppression and reducing stimulant use in San Francisco pilot programme
12 January 2026. Related: Journal scan, Coinfections and complications, Activism & advocacy.
Cancer and women living with HIV: results from D:A:D and RESPOND support including screening in routine HIV care
11 January 2026. Related: Journal scan, Women's health, Cancer and HIV.
Confirmed safety of kidney transplant when both recipient and donor are HIV positive
11 January 2026. Related: Journal scan, Coinfections and complications, Cancer and HIV, Hepatitis coinfection.
Neutralising antibodies wane two years after mpox infection or vaccination: protection persists
10 January 2026. Related: Journal scan, mpox.
Importance of rapid PEP: predicting impact of delay and duration of 2- and 3-drug PEP
23 November 2025. Related: Journal scan, HIV prevention and transmission.
Case of functional cure reported in an elite controller after 22 years without ART
23 November 2025. Related: Journal scan, Cure-related research.
Lenacapavir drug resistance: rapid switching and the need for resistance testing
23 November 2025. Related: Journal scan, Antiretrovirals, Drug resistance.
Australian survey reports limited interest in CAB-LA PrEP by gay and bisexual men
22 November 2025. Related: Journal scan, Treatment access, HIV prevention and transmission.
Call to drop abacavir from use in adults
13 July 2025. Related: Journal scan, Antiretrovirals, Treatment strategies, Coinfections and complications.
Risk of metabolic syndrome when starting ART with bictegravir vs dolutegravir
7 June 2025. Related: Journal scan, Side effects, Weight, diabetes, metabolic complications.
Featured Latest news on the US crisis and its impact on global health
1 June 2025. Related: Journal scan, Special reports, Treatment access, Activism & advocacy.
Vaccination is effective in limiting mpox progression – but lower efficacy in people living with HIV
27 May 2025. Related: Journal scan, mpox.
HIV activists in the US call for action in JID and Zachie Achmat brings South African perspective in the Lancet
26 May 2025. Related: Journal scan, Treatment access, Activism & advocacy.
Combining injectable lenacapavir and cabotegravir-LA
23 May 2025. Related: Journal scan, Antiretrovirals, Treatment strategies, Treatment access.
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025. Related: Journal scan, Treatment strategies, Drug resistance.
Lancet Commission on gender justice and equality
9 April 2025. Related: Journal scan.
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025. Related: Journal scan, Special reports, Treatment access.